Humana (HUM) Payables (2009 - 2026)

Humana (HUM) has reported Payables for 18 consecutive years, with $7.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 29.38% year-over-year to $7.6 billion in Q2 2026; TTM through Jun 2026 was $7.6 billion, a 29.38% increase from a year earlier, with the FY2025 full-year figure at $6.0 billion, up 6.38% from the prior year.
• Payables was $7.6 billion for Q2 2026 at Humana, up from $6.8 billion in the prior quarter.
• Over five years, Payables peaked at $8.6 billion in Q2 2023 and troughed at $5.5 billion in Q4 2022.
• A 5-year average of $6.6 billion and a median of $6.5 billion in 2024 frame the typical range for Payables.
• Across the five-year window, Payables surged 38.8% in 2023 and declined 20.07% in 2024, its largest moves.
• Over 5 years, Payables stood at $5.5 billion in 2022, then advanced by 25.04% to $6.9 billion in 2023, then decreased by 18.2% to $5.7 billion in 2024, then advanced by 6.38% to $6.0 billion in 2025, then advanced by 26.42% to $7.6 billion in 2026.
• The last three Payables figures came in at $7.6 billion (Q2 2026), $6.8 billion (Q1 2026), and $6.0 billion (Q4 2025), per Business Quant data.